About BlackRock

WHO WE ARE

BlackRock is trusted to manage more money than any other investment manager in the world, helping millions of people and the world’s biggest institutions and governments reach their investing goals.

Source: BlackRock. Based on $6.52 trillion in AUM as of 03/31/19

Our Company and Sites

IHE

iShares U.S. Pharmaceuticals ETF

Equity

IHE

iShares U.S. Pharmaceuticals ETF

Overview

Why IHE?

1. Exposure to U.S. companies that manufacture prescription or over-the-counter drugs or vaccines

 

2. Targeted access to domestic pharmaceutical stocks

 

3. Use to express a sector view

INVESTMENT OBJECTIVE

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.
Loading

Performance

Performance

  • Returns

  1y 3y 5y 10y Incept.
Total Return (%) Total return represents changes to the NAV and accounts for distributions from the fund. 0.97 2.67 3.56 14.11 10.29
Market Price (%) Market price return represents changes to the midpoint price and accounts for distributions from the fund. The midpoint is the average of the bid-ask prices at 4:00 PM ET (when NAV is normally determined for most funds). 0.93 2.65 3.55 14.09 10.28
Benchmark (%) Index: Dow Jones U.S. Select Pharmaceuticals Index 1.14 2.87 3.83 14.49 10.70
After Tax Pre-Liq. (%) Return after taxes on distributions. Assumes fund shares have not been sold. 0.68 2.37 3.24 13.78 10.00
After Tax Post-Liq. (%) Return after taxes on distributions and sale of fund shares. 0.78 2.04 2.75 11.90 8.66
  YTD 1m 3m 6m 1y 3y 5y 10y Incept.
Total Return (%) Total return represents changes to the NAV and accounts for distributions from the fund. 7.94 7.30 -1.74 7.94 0.97 8.21 19.11 274.23 263.04
Market Price (%) Market price return represents changes to the midpoint price and accounts for distributions from the fund. The midpoint is the average of the bid-ask prices at 4:00 PM ET (when NAV is normally determined for most funds). 7.82 7.25 -1.76 7.82 0.93 8.18 19.06 273.80 262.77
Benchmark (%) Index: Dow Jones U.S. Select Pharmaceuticals Index 8.07 7.35 -1.70 8.07 1.14 8.85 20.69 286.89 281.35
After Tax Pre-Liq. (%) Return after taxes on distributions. Assumes fund shares have not been sold. 7.75 7.20 -1.83 7.75 0.68 7.27 17.27 263.71 250.56
After Tax Post-Liq. (%) Return after taxes on distributions and sale of fund shares. 4.83 4.38 -0.97 4.83 0.78 6.25 14.55 207.91 198.49
  2014 2015 2016 2017 2018
Total Return (%) Total return represents changes to the NAV and accounts for distributions from the fund. 29.75 8.81 -11.72 10.66 -7.67
Market Price (%) Market price return represents changes to the midpoint price and accounts for distributions from the fund. The midpoint is the average of the bid-ask prices at 4:00 PM ET (when NAV is normally determined for most funds). 29.71 8.86 -11.66 10.59 -7.65
Benchmark (%) Index: Dow Jones U.S. Select Pharmaceuticals Index 29.55 9.39 -11.42 10.90 -7.56
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.

Growth of Hypothetical $10,000 The growth of hypothetical $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.

Performance chart data not available for display.
View full chart
The Hypothetical Growth of $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted, and numbers may reflect small variances due to rounding. Standardized performance and performance data current to the most recent month end may be found in the Performance section.

Distributions

Ex-Date Total Distribution Income
View full table
Distributions Schedule
Record Date Ex-Date Payable Date Total Distribution Current year distributions are not classified as “Income,” “Short-Term Capital Gains,” “Long-Term Capital Gains,” or “Return of Capital” until calendar year-end. Income ST Cap Gains LT Cap Gains Return of Capital

Premium/Discount

View full chart

Portfolio Characteristics

Portfolio Characteristics

P/E Ratio The price-to-earnings (P/E) ratio is a fundamental measure used to determine if an investment is valued appropriately. Each holding's P/E is the latest closing price divided by the latest fiscal year's earnings per share. Negative P/E ratios are excluded from this calculation. as of Jul 15, 2019 26.18
P/B Ratio The price-to-book value (P/B) ratio is a fundamental measure used to determine if an investment is valued appropriately. The book value of a company is a measure of how much a company's assets are worth assuming the company's debts are paid off. Each holding's P/B is the latest closing price divided by the latest fiscal year's book value per share. Negative book values are excluded from this calculation. as of Jul 15, 2019 2.84
Equity Beta (3y) Beta is a measure of the tendency of securities to move with the market as a whole. A beta of 1 indicates that the security&#39;s price will move with the market. A beta less than 1 indicates the security tends to be less volatile than the market, while a beta greater than 1 indicates the security is more volatile than the market.<br/><br/>Calculated vs. S&amp;P 500 as of Jun 30, 2019 1.05
Standard Deviation (3y) Standard deviation measures how dispersed returns are around the average. A higher standard deviation indicates that returns are spread out over a larger range of values and thus, more volatile. as of Jun 30, 2019 15.82%
Distribution Yield The annual yield an investor would receive if the most recent fund distribution and current fund price stayed the same going forward. It’s calculated by annualizing the most recent distribution and dividing by the fund’s net asset value (NAV) from the as-of date. as of Jun 30, 2019 1.46%
12m Trailing Yield The yield an investor would have received if they had held the fund over the last twelve months assuming the most recent NAV. The 12-Month yield is calculated by assuming any income distributions over the past twelve months and dividing by the sum of the most recent NAV and any capital gain distributions made over the past twelve months. as of Jun 30, 2019 1.22%
30 Day SEC Yield A standard calculation of yield introduced by the SEC in order to provide fairer comparison among funds. This yield reflects the interest earned after deducting the fund&#39;s expenses during the most recent 30-day period by the average investor in the fund. Negative 30-Day SEC Yield results when accrued expenses of the past 30 days exceed the income collected during the past 30 days. as of Jun 30, 2019 1.41%
This information must be preceded or accompanied by a current prospectus. For standardized performance, please see the Performance section above.

Sustainability Characteristics

Sustainability Characteristics

ESG metrics help investors evaluate companies based on environmental, social, and governance risks and opportunities — and the companies’ ability to manage them. They can help investors integrate material, non-financial information into their investment process. Learn more.

MSCI ESG Quality Score The fund&#39;s overall MSCI ESG Quality Score measures the ability of underlying holdings to manage key medium- to long-term risks and opportunities arising from environmental, social, and governance factors. The MSCI ESG Quality Score is calculated as the weighted average of the underlying holding&#39;s ESG Scores. It is provided on a 0-10 scale, with 0 and 10 being the respective lowest and highest possible fund scores. MSCI rates underlying holdings according to their exposure to 37 industry specific ESG risks and their ability to manage those risks relative to peers. These issuer-level ESG ratings correspond to an issuer-level ESG Score. as of Jul 01, 2019 4.4
MSCI ESG Quality Score - Peer Rank The MSCI ESG Quality Score - Peer Rank is a percentile rank (1-100) that measures how the fund&#39;s MSCI ESG Quality Score ranks relative to other funds in the same peer group. as of Jul 01, 2019 10.33%
MSCI ESG % Coverage Percent by weight of a fund&#39;s holdings that have ESG Data. as of Jul 01, 2019 99.16%
Fund Lipper Global Classification The fund peer group as defined by the Lipper Global Classification. as of Jul 01, 2019 Equity Sector Healthcare
MSCI Weighted Average Carbon Intensity
(Tons CO2E/$M SALES) The MSCI Weighted Average Carbon Intensity measures a fund&#39;s exposure to carbon intensive companies. This figure represents the estimated greenhouse gas emissions per $1 million in sales across the fund’s holdings. The figure is a sum of the normalized security weight multiplied by the security Carbon Intensity. This allows for comparisons between funds of different sizes. as of Jul 01, 2019 28.76
Fund Lipper Global Classification Size The number of funds used to calculate the MSCI ESG Quality Score - Peer Rank. This is based on the Lipper Global Classification and reflects the funds that are in the MSCI ESG Fund Metrics coverage universe. as of Jul 01, 2019 213
All data is from MSCI Fund Metrics as of Jul 01, 2019, based on holdings as of Apr 30, 2019.

For newly launched funds, sustainability characteristics are typically available 6 months after launch.

 

To be included in MSCI ESG Fund Metrics, 65% of the fund’s underlying holdings (excluding cash positions) must be covered by MSCI ESG Research, the fund’s holdings date must be less than one year old, and the fund must have at least ten securities.

 

Inclusion of Sustainability Characteristics is not indicative of a fund’s investment objective, nor is it an implication that a fund employs an ESG-related portfolio management strategy.

Fees

Fees

as of current prospectus
Management Fee 0.43%
Acquired Fund Fees and Expenses Acquired Fund Fees and Expenses (“AFFE”) reflect the Fund&#39;s pro rata share of the indirect fees and expenses incurred by investing in one or more acquired funds, such as mutual funds, business development companies, or other pooled investment vehicles. AFFE are reflected in the prices of the acquired funds and thus included in the total returns of the Fund. 0.00%
Foreign Taxes and Other Expenses 0.00%
Expense Ratio As stated in the Fund’s current prospectus. 0.43%
on Jun 30, 2019
Management Fee The Fund’s management fee is subject to breakpoints that are tied to aggregate assets under management across certain groups of iShares ETFs. Breakpoints take effect immediately after asset levels change. On any given day the management fee, and thus the Expense Ratio, may be higher or lower than what is shown in the Fund’s prospectus. For additional information on fees and expenses, please see the Fund’s prospectus. 0.42%
Acquired Fund Fees and Expenses Acquired Fund Fees and Expenses (“AFFE”) reflect the Fund&#39;s pro rata share of the indirect fees and expenses incurred by investing in one or more acquired funds, such as mutual funds, business development companies, or other pooled investment vehicles. AFFE are reflected in the prices of the acquired funds and thus included in the total returns of the Fund. 0.00%
Foreign Taxes and Other Expenses 0.00%
Expense Ratio The Expense Ratio reflects the Fund’s management fee, and any applicable acquired fund fees and expenses, and foreign taxes and other expenses, calculated on the date set forth above. On any given day these fees may be higher or lower than what is shown in the Fund&#39;s prospectus. 0.42%

Holdings

Holdings

Ticker Name Sector Shares Market Value Weight (%) Price Exchange Notional Value
Ticker Name Asset Class Weight (%) Price Shares Market Value Notional Value Sector SEDOL ISIN Exchange
Detailed Holdings and Analytics Detailed portfolio holdings information. Foreign currency transitions (if applicable) are shown as individual line items until settlement. Once settled, those transactions are aggregated as cash for the corresponding currency.
Holdings are subject to change.

Exposure Breakdowns

Exposure Breakdowns

as of Jul 16, 2019

% of Market Value

Type Fund
Allocations are subject to change.

Literature

Literature

Loading fund documents...
No documents found

{{ translations[action] }}
{{ record.profileShortName || record.title }} {{ record.profileShortName || record.title }}